Search results for "Perch"

showing 10 items of 1084 documents

CCDC 1827335: Experimental Crystal Structure Determination

2018

Related Article: Álvaro Martínez-Camarena, Andrea Liberato, Estefanía Delgado-Pinar, Andrés G. Algarra, Javier Pitarch-Jarque, José M. Llinares, M. Ángeles Mañez, Antonio Domenech-Carbó, Manuel G. Basallote, Enrique García-España|2018|Inorg.Chem.|57|10961|doi:10.1021/acs.inorgchem.8b01492

chloro-[6-methyl-39-bis(propan-2-yl)-36915-tetraazabicyclo[9.3.1]pentadeca-1(15)1113-triene]-copper(ii) perchlorateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 709728: Experimental Crystal Structure Determination

2009

Related Article: I.S.Jahro, D.Onggo, Ismunandar, S.I.Rahayu, M.C.Munoz, A.B.Gaspar, M.Seredyuk, P.Gutlich, J.A.Real|2008|Inorg.Chim.Acta|361|4047|doi:10.1016/j.ica.2008.03.122

clambdacdelta-tris(2-(2-Pyridyl)quinoline)-iron(ii) diperchlorateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Apical seal comparison of low-temperature thermoplasticized gutta-percha technique and lateral condensation with two different master cones

2007

Aim: To compare the apical sealing in mesio-buccal canals of extracted molars obturated with low-temperature thermoplasticized gutta-percha or cold lateral condensation techniques using a .06 or a .02 mm/mm tapered gutta-percha master cone. The secondary aim was to evaluate the depth of spreader penetration in root canals using a .06 or a .02 mm/mm tapered gutta-percha master cone. Methodology: Forty-four mesio-buccal curved canals (25-40º) were instrumented with .06 nickel-titanium rotary instruments and randomly distributed into two control groups (n=4) and three experimental groups (n=12) for obturation by the Ultrafil® 3D system or by cold lateral condensation with .06 or .02 tapered ma…

cold lateral condensationgutapercha termoplastificadaUNESCO::CIENCIAS MÉDICASObturación de conductos radicularesRoot canals filling:CIENCIAS MÉDICAS [UNESCO]condensación lateralthermoplasticized gutta-percha
researchProduct

Influencia de la conicidad de la guttapercha en la adaptación a la dentina de los materiales endodóncicos de obturación = Influencia da conicidade da…

2010

Para determinar la posible influencia de la conicidad de la gutapercha en la adaptación de los materiales de obturación a las paredes dentinarias, se obturaron 60 conductos radiculares de dientes humanos mediante tres técnicas de obturación diferentes (condensación lateral, técnica mixta y técnica de la onda continua) utilizando gutapercha de diferentes conicidades; conicidad normalizada (0,02%) y conicidad aumentada (0,004%) formándose 6 grupos de estudio. de 10 especímenes cada uno. Grupo 1 conductos obturados mediante la técnica de la condensación lateral y gutapercha de conicidad normalizada, grupo 2 condensación lateral/conicidad aumentada, grupo 3 técnica mixta/ conicidad normalizada,…

confocalUNESCO::CIENCIAS MÉDICASconicidad:CIENCIAS MÉDICAS [UNESCO]guttaperchaendodoncia
researchProduct

Chlorido(2,2′-{[2-(1-methyl-1H-imidazol-2-yl-κN 3)imidazolidine-1,3-diyl-κN]bis(methylene)}bis(1-methyl-1H-imidazole-κN 3))copper(II) perchlorate

2019

In the crystal structure of the title complex, [CuCl(C17H24N8)]ClO4, the copper(II) metal exhibits an N4Cl pentacoordinate environment in a distorted square-pyramidal geometry. Coordination to the metal centre occurs through the three 1-methylimidazole N atoms from the pendant groups, one amine N atom from the imidazolidine moiety and one chlorido anion. Intermolecular interactions take place at two of the 1-methyl-imidazole rings in the form of parallel-displaced π–π stacking interactions forming chains parallel to the a axis. Three O atoms of the perchlorate anion are rotationally disordered between two orientations with occupancies of 0.5.

crystal structureCrystallographyCopper(II) perchlorate010405 organic chemistrychemistry.chemical_elementGeneral ChemistryCrystal structure010402 general chemistryCondensed Matter Physics01 natural sciencesMedicinal chemistryCopper0104 chemical sciencesPerchloratechemistry.chemical_compoundchemistryQD901-999ImidazolidineImidazoleMoietyGeneral Materials Scienceimidazolidine ligandEne reactioncopper complexActa Crystallographica Section E Crystallographic Communications
researchProduct

Ferro- and Antiferromagnetic Interactions in Oxalato-Centered Inverse Hexanuclear and Chain Copper(II) Complexes with Pyrazole Derivatives.

2021

Two novel copper(II) complexes of formulas {[Cu(4-Hmpz)4][Cu(4-Hmpz)2(µ3-ox-κ2O1,O2:κO2′:κO1′)(ClO4)2]}n (1) and {[Cu(3,4,5-Htmpz)4]2[Cu(3,4,5-Htmpz)2(µ3-ox-κ2O1,O2:κO2′:κO1′)(H2O)(ClO4)]2[Cu2(3,4,5-Htmpz)4(µ-ox-κ2O1,O2:κ2O2′,O1′)]}(ClO4)4·6H2O (2) have been obtained by using 4-methyl-1H-pyrazole (4-Hmpz) and 3,4,5-trimethyl-1H-pyrazole (3,4,5-Htmpz) as terminal ligands and oxalate (ox) as the polyatomic inverse coordination center. The crystal structure of 1 consists of perchlorate counteranions and cationic copper(II) chains with alternating bis(pyrazole)(µ3-κ2O1,O2:κO2′:κO1′-oxalato)copper(II) and tetrakis(pyrazole)copper(II) fragments. The crystal structure of 2 is made up of perchlorat…

crystal structurePharmaceutical Sciencechemistry.chemical_elementCrystal structurePyrazoleOxalateArticleAnalytical ChemistryPerchloratechemistry.chemical_compoundQD241-441TheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITYDrug DiscoveryAntiferromagnetismPhysical and Theoretical Chemistrypolynuclear complexesOrganic ChemistryPolyatomic ioninverse coordination chemistryoxalatoCopperpyrazoleCrystallographycoordination polymerschemistryChemistry (miscellaneous)Intramolecular forcecopperMolecular Medicinemagnetic propertiesMolecules (Basel, Switzerland)
researchProduct

Crystal structure of bis-(2-methyl-1H-imidazole-κN (3))(meso-tetra-p-tol-ylporphyrinato-κ(4) N)iron(III) perchlorate tetra-hydro-furan sesquisolvate.

2016

The crystal structure of the six-coordinate, highly ruffled, ferric porphyrinate bis­(2-methyl­imidazole)[meso-tetra­kis­(p-tol­yl)porphyrinato]iron(III) perchlorate is reported.

crystal structureStereochemistryCrystal structureDihedral angle010402 general chemistry010403 inorganic & nuclear chemistry2-methylimidazole01 natural sciencesResearch CommunicationsPerchloratechemistry.chemical_compoundhighly ruffled porphyrin coremeso-tetra­kis­(p-tol­yl)porphyrinatoImidazoleGeneral Materials ScienceCrystallography2-methyl­imidazoleLigandHydrogen bondGeneral ChemistryCondensed Matter Physicshydrogen bondingPorphyrinmeso-tetrakis(p-tolyl)porphyrinato0104 chemical sciencesBond lengthCrystallographychemistryQD901-999iron(III)Acta crystallographica. Section E, Crystallographic communications
researchProduct

Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia …

2020

The growing insights in the next-generation immunotherapy and the state-of-the-art advancement in targeted-agents significantly improved clinical outcome of cancer patients by pointing towards a unexplored Achilles' heel. Novel toxicity profiles have been uncovered, representing unmet medical needs. Thus, a panel of expert provide comprehensive pharmacological and clinical evidence, to provide a patient-tailored approach to metabolic adverse events associated with novel anti-cancer treatments. Prompted by the need of a multidisciplinary cooperation, a working group of Associazione Italiana Oncologia Medica (AIOM), Associazione Medici Diabetologi (AMD) and Societa Italiana Farmacologia (SIF)…

diabetes; dyslipidemia; hypercholesterolemia; hyperglycemia; hypertriglyceridemia; immunotherapy; metabolic effect; targeted therapy; Consensus; Humans; Immunologic Factors; Italy; Medical Oncology; Neoplasms; Physicians0301 basic medicinemedicine.medical_specialtyConsensusSettore MED/06 - Oncologia MedicaImmune checkpoint inhibitorsmedicine.medical_treatmentPatient riskhypertriglyceridemiaMedical OncologyTargeted therapy03 medical and health sciences0302 clinical medicineMultidisciplinary approachNeoplasmsPhysiciansmedicineHumansImmunologic FactorsIntensive care medicineAdverse effectdiabeteshypercholesterolemiabusiness.industrydyslipidemiametabolic effectHematologytargeted therapy030104 developmental biologyOncologyItalyClinical evidence030220 oncology & carcinogenesisMetabolic effectsPosition paperhyperglycemiaimmunotherapybusiness
researchProduct

CCDC 882806: Experimental Crystal Structure Determination

2013

Related Article: F.Reuter,E.Rentschler|2013|Polyhedron|52|788|doi:10.1016/j.poly.2012.07.050

diaqua-bis(110-phenanthroline)-(mu~2~-NNN'N'-tetrakis(2-pyridylmethyl)benzene-14-diamine)-di-manganese(ii) tetraperchlorate ethanol methanol solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 882811: Experimental Crystal Structure Determination

2013

Related Article: F.Reuter,E.Rentschler|2013|Polyhedron|52|788|doi:10.1016/j.poly.2012.07.050

diaqua-bis(110-phenanthroline)-(mu~2~-NNN'N'-tetrakis(2-pyridylmethyl)benzene-14-diamine)-nickel(ii)-manganese(ii) tetraperchlorate ethanol methanol solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct